PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Emergency Medicine and Internal Medicine, Highland Hospital-Alameda Health System, Oakland, CA, United States of America; California Bridge Program, Public Health Institute, United States of America; University of California, San Francisco, San Francisco, CA, United States of America. Electronic address: aherring@alamedahealthsystem.org.\', \'Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America.\', \'Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America.\', \'Department of Family Medicine, University of California, Los Angeles, Los Angeles, CA, United States of America; Division of Infectious Diseases, University of California, Los Angeles, Los Angeles, CA, United States of America.\', \'Department of Family and Community Medicine, University of California, San Francisco, San Francisco, CA, United States of America; California Bridge Program, Public Health Institute, United States of America.\', \'California Bridge Program, Public Health Institute, United States of America; Department of Emergency Medicine, Marshall Medical Center, Placerville, CA, United States of America.\', \'California Bridge Program, Public Health Institute, United States of America; Department of Emergency Medicine and Psychiatry, UC Davis Medical Center, Sacramento, CA, United States of America.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0740-5472(20)30517-110.1016/j.jsat.2020.108260
?:hasPublicationType
?:journal
  • Journal of substance abuse treatment
is ?:pmid of
?:pmid
?:pmid
  • 33612194
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.311
?:rankingScore_hIndex
  • 91
is ?:relation_isRelatedTo_publication of
?:title
  • Sharp decline in hospital and emergency department initiated buprenorphine for opioid use disorder during COVID-19 state of emergency in California.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all